4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide

C160H161F4N39O10 — CID 159098014

About 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide

4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide (PubChem CID 159098014) has the molecular formula C160H161F4N39O10 and a molecular weight of 2866.30 g/mol. Its IUPAC name is 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide.

Molecular Properties

• Compound Name: 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide
• PubChem CID: 159098014
• Molecular Formula: C160H161F4N39O10
• Molecular Weight: 2866.30 g/mol
• Exact Mass: 2864.32
• IUPAC Name: 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide
• SMILES: CN(C)[C@@H]1CCN(c2ccnc3c2cc(C#N)c2nc4ccccc4n23)C1.CN1CCCN(c2ccnc3c2cc(C#N)c2nc4cc5c(cc4n23)OCO5)CC1.CNC(=O)c1cc2c(N3CCCN(C)CC3)ccnc2n2c1nc1cc3c(cc12)OCO3.CNC(=O)c1cc2c(N3CCCN(C)CC3)ccnc2n2c1nc1ccc(C)cc12.CNC(=O)c1cc2c(N3C[C@H](C)C[C@H](C)C3)cc(C)nc2n2c1nc1cc(F)c(F)cc12.CNC(=O)c1cc2c(N3C[C@H](C)C[C@H](C)C3)cc(C)nc2n2c1nc1cc3c(cc12)OCO3.C[C@@H]1C[C@H](C)CN(c2ccnc3c2cc(C#N)c2nc4cc(F)c(F)cc4n23)C1
• InChI: InChI=1S/C25H27N5O3.C24H25F2N5O.C23H24N6O3.C23H26N6O.C22H19F2N5.C22H20N6O2.C21H20N6/c1-13-5-14(2)11-29(10-13)19-6-15(3)27-23-16(19)7-17(25(31)26-4)24-28-18-8-21-22(33-12-32-21)9-20(18)30(23)24;1-12-5-13(2)11-30(10-12)20-6-14(3)28-22-15(20)7-16(24(32)27-4)23-29-19-8-17(25)18(26)9-21(19)31(22)23;1-24-23(30)15-10-14-17(28-7-3-6-27(2)8-9-28)4-5-25-21(14)29-18-12-20-19(31-13-32-20)11-16(18)26-22(15)29;1-15-5-6-18-20(13-15)29-21-16(14-17(22(29)26-18)23(30)24-2)19(7-8-25-21)28-10-4-9-27(3)11-12-28;1-12-5-13(2)11-28(10-12)19-3-4-26-22-15(19)6-14(9-25)21-27-18-7-16(23)17(24)8-20(18)29(21)22;1-26-5-2-6-27(8-7-26)17-3-4-24-22-15(17)9-14(12-23)21-25-16-10-19-20(30-13-29-19)11-18(16)28(21)22;1-25(2)15-8-10-26(13-15)18-7-9-23-21-16(18)11-14(12-22)20-24-17-5-3-4-6-19(17)27(20)21/h6-9,13-14H,5,10-12H2,1-4H3,(H,26,31);6-9,12-13H,5,10-11H2,1-4H3,(H,27,32);4-5,10-12H,3,6-9,13H2,1-2H3,(H,24,30);5-8,13-14H,4,9-12H2,1-3H3,(H,24,30);3-4,6-8,12-13H,5,10-11H2,1-2H3;3-4,9-11H,2,5-8,13H2,1H3;3-7,9,11,15H,8,10,13H2,1-2H3/t13-,14+;12-,13+;;;12-,13+;;15-/m......1/s1
• InChIKey: KCXKRHORTBEJSA-FXYWAONKSA-N
• XLogP: 23.98
• TPSA: 490.12 Ų
• H-Bond Donors: 4
• H-Bond Acceptors: 45
• Rotatable Bonds: 12
• Heavy Atoms: 213
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2866.30
LogP ≤ 5	23.98
H-Bond Donors ≤ 5	4
H-Bond Acceptors ≤ 10	45

Frequently Asked Questions

What is the IUPAC name of 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide?

The IUPAC name of 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide (CID 159098014) is 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide.

What is the SMILES notation for 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide?

The canonical SMILES for 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide is CN(C)[C@@H]1CCN(c2ccnc3c2cc(C#N)c2nc4ccccc4n23)C1.CN1CCCN(c2ccnc3c2cc(C#N)c2nc4cc5c(cc4n23)OCO5)CC1.CNC(=O)c1cc2c(N3CCCN(C)CC3)ccnc2n2c1nc1cc3c(cc12)OCO3.CNC(=O)c1cc2c(N3CCCN(C)CC3)ccnc2n2c1nc1ccc(C)cc12.CNC(=O)c1cc2c(N3C[C@H](C)C[C@H](C)C3)cc(C)nc2n2c1nc1cc(F)c(F)cc12.CNC(=O)c1cc2c(N3C[C@H](C)C[C@H](C)C3)cc(C)nc2n2c1nc1cc3c(cc12)OCO3.C[C@@H]1C[C@H](C)CN(c2ccnc3c2cc(C#N)c2nc4cc(F)c(F)cc4n23)C1.

What is the InChIKey of 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide?

The InChIKey is KCXKRHORTBEJSA-FXYWAONKSA-N. The full InChI is InChI=1S/C25H27N5O3.C24H25F2N5O.C23H24N6O3.C23H26N6O.C22H19F2N5.C22H20N6O2.C21H20N6/c1-13-5-14(2)11-29(10-13)19-6-15(3)27-23-16(19)7-17(25(31)26-4)24-28-18-8-21-22(33-12-32-21)9-20(18)30(23)24;1-12-5-13(2)11-30(10-12)20-6-14(3)28-22-15(20)7-16(24(32)27-4)23-29-19-8-17(25)18(26)9-21(19)31(22)23;1-24-23(30)15-10-14-17(28-7-3-6-27(2)8-9-28)4-5-25-21(14)29-18-12-20-19(31-13-32-20)11-16(18)26-22(15)29;1-15-5-6-18-20(13-15)29-21-16(14-17(22(29)26-18)23(30)24-2)19(7-8-25-21)28-10-4-9-27(3)11-12-28;1-12-5-13(2)11-28(10-12)19-3-4-26-22-15(19)6-14(9-25)21-27-18-7-16(23)17(24)8-20(18)29(21)22;1-26-5-2-6-27(8-7-26)17-3-4-24-22-15(17)9-14(12-23)21-25-16-10-19-20(30-13-29-19)11-18(16)28(21)22;1-25(2)15-8-10-26(13-15)18-7-9-23-21-16(18)11-14(12-22)20-24-17-5-3-4-6-19(17)27(20)21/h6-9,13-14H,5,10-12H2,1-4H3,(H,26,31);6-9,12-13H,5,10-11H2,1-4H3,(H,27,32);4-5,10-12H,3,6-9,13H2,1-2H3,(H,24,30);5-8,13-14H,4,9-12H2,1-3H3,(H,24,30);3-4,6-8,12-13H,5,10-11H2,1-2H3;3-4,9-11H,2,5-8,13H2,1H3;3-7,9,11,15H,8,10,13H2,1-2H3/t13-,14+;12-,13+;;;12-,13+;;15-/m......1/s1.

What are the key properties of 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide?

4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide has a molecular weight of 2866.30 g/mol, XLogP of 23.98, 12 rotatable bonds, 4 hydrogen bond donors, and 45 hydrogen bond acceptors.

Where does this data come from?

All data for 4-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]benzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;N,10-dimethyl-4-(4-methyl-1,4-diazepan-1-yl)benzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluorobenzimidazolo[1,2-a][1,8]naphthyridine-6-carbonitrile;4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-9,10-difluoro-N,2-dimethylbenzimidazolo[1,2-a][1,8]naphthyridine-6-carboxamide;16-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-N,18-dimethyl-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide;16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carbonitrile;N-methyl-16-(4-methyl-1,4-diazepan-1-yl)-5,7-dioxa-1,11,19-triazapentacyclo[10.8.0.02,10.04,8.015,20]icosa-2,4(8),9,11,13,15,17,19-octaene-13-carboxamide is sourced from PubChem (CID 159098014), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).